ES2194312T3 - Compuestos de polimero-platino. - Google Patents

Compuestos de polimero-platino.

Info

Publication number
ES2194312T3
ES2194312T3 ES98918020T ES98918020T ES2194312T3 ES 2194312 T3 ES2194312 T3 ES 2194312T3 ES 98918020 T ES98918020 T ES 98918020T ES 98918020 T ES98918020 T ES 98918020T ES 2194312 T3 ES2194312 T3 ES 2194312T3
Authority
ES
Spain
Prior art keywords
polymer
platinum compound
platinum
platinum compounds
side chains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98918020T
Other languages
English (en)
Inventor
Ruth Duncan
Evagoras G Evagorou
Robert G Buckley
Elisabetta Gianasi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abeona Therapeutics Inc
Original Assignee
Access Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Access Pharmaceuticals Inc filed Critical Access Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2194312T3 publication Critical patent/ES2194312T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Electroplating And Plating Baths Therefor (AREA)

Abstract

Una composición que comprende un complejo de polímero-platino diseñado para acumularse en el sitio de un tumor, y compuesto de un polímero de N-alquil-acrilamida que tiene cadenas laterales espaciadas a lo largo del polímero para formar complejo con un compuesto de platino, y dichas cadenas laterales (i) están compuestas de un oligopéptido unido por un extremo al polímero y por el otro extremo al compuesto de platino, y (ii) incluyen al menos una unión que está diseñada para ser escindida en condiciones fisiológicas seleccionadas para dar el compuesto de platino que tiene, o se convierte in vivo para tener, actividad antitumoral.
ES98918020T 1997-04-18 1998-04-15 Compuestos de polimero-platino. Expired - Lifetime ES2194312T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4474397P 1997-04-18 1997-04-18

Publications (1)

Publication Number Publication Date
ES2194312T3 true ES2194312T3 (es) 2003-11-16

Family

ID=21934085

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98918020T Expired - Lifetime ES2194312T3 (es) 1997-04-18 1998-04-15 Compuestos de polimero-platino.

Country Status (12)

Country Link
US (1) US5965118A (es)
EP (1) EP1009439B1 (es)
JP (2) JP4536165B2 (es)
AT (1) ATE230613T1 (es)
AU (1) AU736297B2 (es)
CA (1) CA2286091C (es)
DE (1) DE69810636T2 (es)
DK (1) DK1009439T3 (es)
ES (1) ES2194312T3 (es)
TW (1) TW509573B (es)
WO (1) WO1998047537A1 (es)
ZA (1) ZA983250B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006222657B2 (en) * 2000-01-04 2009-01-15 Access Pharmaceuticals, Inc. N,O-amidomalonate platinum complexes
US6692734B2 (en) * 2000-01-04 2004-02-17 Access Pharmaceuticals, Inc. N,O-amidomalonate platinum complexes
US7166733B2 (en) * 2000-01-04 2007-01-23 Access Pharmaceuticals, Inc. O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes
DE60131177T2 (de) 2000-09-06 2008-08-07 AP Pharma, Inc., Redwood Abbaubare polyacetal-polymere
SG92833A1 (en) 2001-03-27 2002-11-19 Sumitomo Chemical Co Polymeric light emitting substance and polymer light emitting device using the same
KR100484504B1 (ko) * 2001-09-18 2005-04-20 학교법인 포항공과대학교 쿠커비투릴 유도체를 주인 분자로서 포함하고 있는 내포화합물 및 이를 포함한 약제학적 조성물
WO2005002508A2 (en) * 2003-06-11 2005-01-13 Access Pharmaceuticals, Inc. Macromolecular platinum chelates
EP2077290B1 (en) 2005-12-05 2010-04-21 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods
CN101730549B (zh) * 2007-05-09 2015-12-09 日东电工株式会社 与铂类药物结合的聚合物
CN102264396A (zh) * 2008-10-07 2011-11-30 瑞沙恩医药公司 Hpma-多西他赛或吉西他滨缀合物及其用途
WO2011047051A2 (en) * 2009-10-13 2011-04-21 Rexahn Pharmaceuticals, Inc. Polymeric systems for the delivery of anticancer agents
EP2743273A1 (de) * 2012-12-12 2014-06-18 Umicore AG & Co. KG Verfahren zur Herstellung wasserhaltiger Zubereitungen von Komplexen der Platingruppenmetalle

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS173846B1 (es) * 1974-04-23 1977-03-31
CS173849B1 (es) * 1974-04-25 1977-03-31
IL73972A0 (en) * 1984-12-31 1985-03-31 Yeda Res & Dev Agents based on platinum compounds
GB8500209D0 (en) * 1985-01-04 1985-02-13 Ceskoslovenska Akademie Ved Synthetic polymeric drugs
IN165717B (es) * 1986-08-07 1989-12-23 Battelle Memorial Institute
US4931553A (en) * 1988-05-11 1990-06-05 Gill Devinder S Platinum-polymer complexes and their use as antitumor agents
US5420105A (en) * 1988-09-23 1995-05-30 Gustavson; Linda M. Polymeric carriers for non-covalent drug conjugation
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents
US5484584A (en) * 1990-10-02 1996-01-16 Board Of Regents, The University Of Texas System Therapeutic and diagnostic use of modified polymeric microcapsules
GB9026491D0 (en) * 1990-12-05 1991-01-23 Erba Carlo Spa Anthracycline-conjugates
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
GB9213077D0 (en) * 1992-06-19 1992-08-05 Erba Carlo Spa Polymerbound taxol derivatives
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
KR0164460B1 (ko) * 1995-10-02 1999-03-20 김은영 고분자 백금 착화합물, 그의 제조방법 및 그를 유효성분으로 하는 항암제

Also Published As

Publication number Publication date
AU736297B2 (en) 2001-07-26
EP1009439A1 (en) 2000-06-21
DE69810636T2 (de) 2003-11-06
AU7102698A (en) 1998-11-13
US5965118A (en) 1999-10-12
CA2286091A1 (en) 1998-10-29
JP4536165B2 (ja) 2010-09-01
CA2286091C (en) 2010-07-06
JP2001524098A (ja) 2001-11-27
WO1998047537A1 (en) 1998-10-29
ATE230613T1 (de) 2003-01-15
TW509573B (en) 2002-11-11
DE69810636D1 (de) 2003-02-13
DK1009439T3 (da) 2003-05-05
EP1009439B1 (en) 2003-01-08
JP2010132685A (ja) 2010-06-17
ZA983250B (en) 1998-10-18

Similar Documents

Publication Publication Date Title
MX170060B (es) Montaje de reflector con protector termico
BR9910251A (pt) Estimulação hematopoiética
CO4900090A1 (es) Camisa de proteccion floral que tiene un patron decorativo
CL2004000675A1 (es) Uso de una combinacion de androgeno de origen biogenico o sintetico y un estrogeno de origen biogenico o sintetico para preparar un medicamento util en el tratamiento del hipogonadismo y enfermedades hipofisis o glandula pituitaria en hombres, para e
AR242900A1 (es) Estructura absorbente que tiene un lado frontal al cuerpo y un lado frontal a la prenda.
MX170029B (es) Composicion fundida por calor, curable con humedad que no forma hebras
ES2129067T3 (es) Clavo de medula.
AR017264A1 (es) Agente blanqueador
ES2164836T3 (es) Patas de retencion de un componente.
ES2193406T3 (es) Composiciones y metodos para mejorar la funcion intestinal.
ATE133181T1 (de) Dehydrodidemnin b
ES2103774T3 (es) Dispositivo de coagulacion a gas.
GT199900214A (es) Combinacion de cerivastatina y fibratos.
EE04363B1 (et) Kokkupõrkekindel kaheseinaline tarind
MX9300550A (es) Estructura de fibra absorbente.
MX170185B (es) , "mejoras en fibras cortas y composiciones elastomericas reforzada que contiene fibras cortas
EP0414007A3 (en) A novel arginine deiminase, its manufacturing method and an anti-cancer agent containing this enzyme as an effective ingredient
AR017150A1 (es) Articulo absorbente higienico que tiene alas.
ES2061770T3 (es) Antibioticos tan-1057.
ES2151517T3 (es) Efectos de filamentos de actina sobre la estructura y lisis de coagulos de fibrina.
DK1009439T3 (da) Polymer-platin-forbindelser
CR5352A (es) Cepillo para retencion mejorada de cerdas y enclaje de alambre del mismo
MX171818B (es) Tablero de fibras marcadas que tiene moldeabilidad mejorada
IT251494Y1 (it) Bracciale tecnico ad alta visibilita' del tipo con tasca
AR035249A1 (es) Un articulo absorbente